MT1X and nonpapillary renal cell carcinoma: We evaluated MT1X with Kaplan–Meier plotter and found that increased expression of MT1X in ccRCC predicts unfavorable OS (n=530, HR [hazard ratio] = 2, P<0.001) (Figure 3A).